Search

Your search keyword '"Tripodo, C"' showing total 757 results
Start Over Author "Tripodo, C"
757 results on '"Tripodo, C"'

3. A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia

Author

Menin, L, Weber, J, Villa, S, Martini, E, Maspero, E, Niño, C, Cancila, V, Poli, A, Maiuri, P, Palamidessi, A, Frittoli, E, Bianchi, F, Tripodo, C, Walters, K, Giavazzi, F, Scita, G, Polo, S, Menin L., Weber J., Villa S., Martini E., Maspero E., Niño C. A., Cancila V., Poli A., Maiuri P., Palamidessi A., Frittoli E., Bianchi F., Tripodo C., Walters K. J., Giavazzi F., Scita G., Polo S., Menin, L, Weber, J, Villa, S, Martini, E, Maspero, E, Niño, C, Cancila, V, Poli, A, Maiuri, P, Palamidessi, A, Frittoli, E, Bianchi, F, Tripodo, C, Walters, K, Giavazzi, F, Scita, G, Polo, S, Menin L., Weber J., Villa S., Martini E., Maspero E., Niño C. A., Cancila V., Poli A., Maiuri P., Palamidessi A., Frittoli E., Bianchi F., Tripodo C., Walters K. J., Giavazzi F., Scita G., and Polo S.

Abstract

Tissue fluidification and collective motility are pivotal in regulating embryonic morphogenesis, wound heal-ing, and tumor metastasis. These processes frequently require that each cell constituent of a tissue coordi-nates its migration activity and directed motion through the oriented extension of lamellipodium cell protru-sions, promoted by RAC1 activity. While the upstream RAC1 regulators in individual migratory cells or leader cells during invasion or wound healing are well characterized, how RAC1 is controlled in follower cells re-mains unknown. Here, we identify a MYO6-DOCK7 axis essential for spatially restricting RAC1 activity in a planar polarized fashion in model tissue monolayers. The MYO6-DOCK7 axis specifically controls the exten-sion of cryptic lamellipodia required to drive tissue fluidification and cooperative-mode motion in otherwise solid and static carcinoma cell collectives.

Published
2023

4. Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue

Author

Ciavarella, S., Vegliante, M.C., Fabbri, M., De Summa, S., Melle, F., Motta, G., De Iuliis, V., Opinto, G., Enjuanes, A., Rega, S., Gulino, A., Agostinelli, C., Scattone, A., Tommasi, S., Mangia, A., Mele, F., Simone, G., Zito, A.F., Ingravallo, G., Vitolo, U., Chiappella, A., Tarella, C., Gianni, A.M., Rambaldi, A., Zinzani, P.L., Casadei, B., Derenzini, E., Loseto, G., Pileri, A., Tabanelli, V., Fiori, S., Rivas-Delgado, A., López-Guillermo, A., Venesio, T., Sapino, A., Campo, E., Tripodo, C., Guarini, A., and Pileri, S.A.

Published
2018
Full Text
View/download PDF

6. A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.)

Author

Di Napoli, Arianna, Remotti, D., Agostinelli, C., Ambrosio, M. R., Ascani, S., Carbone, A., Facchetti, F., Lazzi, S., Leoncini, L., Lucioni, M., Novero, D., Pileri, S., Ponzoni, M., Sabattini, E., Tripodo, C., Zamò, A., Paulli, M., and Ruco, L.

Published
2019
Full Text
View/download PDF

7. Author Correction: Tissue fluidification promotes a cGAS–STING cytosolic DNA response in invasive breast cancer (Nature Materials, (2022), 10.1038/s41563-022-01431-x)

Author

Frittoli E., Palamidessi A., Iannelli F., Zanardi F., Villa S., Barzaghi L., Abdo H., Cancila V., Beznoussenko G. V., Della Chiara G., Pagani M., Malinverno C., Bhattacharya D., Pisati F., Yu W., Galimberti V., Bonizzi G., Martini E., Mironov A. A., Gioia U., Ascione F., Li Q., Havas K., Magni S., Lavagnino Z., Pennacchio F. A., Maiuri P., Caponi S., Mattarelli M., Martino S., d'Adda di Fagagna F., Rossi C., Lucioni M., Tancredi R., Pedrazzoli P., Vecchione A., Petrini C., Ferrari F., Lanzuolo C., Bertalot G., Nader G., Foiani M., Piel M., Cerbino R., Giavazzi F., Tripodo C., Scita G., Frittoli E., Palamidessi A., Iannelli F., Zanardi F., Villa S., Barzaghi L., Abdo H., Cancila V., Beznoussenko G.V., Della Chiara G., Pagani M., Malinverno C., Bhattacharya D., Pisati F., Yu W., Galimberti V., Bonizzi G., Martini E., Mironov A.A., Gioia U., Ascione F., Li Q., Havas K., Magni S., Lavagnino Z., Pennacchio F.A., Maiuri P., Caponi S., Mattarelli M., Martino S., d'Adda di Fagagna F., Rossi C., Lucioni M., Tancredi R., Pedrazzoli P., Vecchione A., Petrini C., Ferrari F., Lanzuolo C., Bertalot G., Nader G., Foiani M., Piel M., Cerbino R., Giavazzi F., Tripodo C., and Scita G.

Subjects
c-gas, Settore MED/05 - Patologia Clinica, Settore MED/08 - Anatomia Patologica
Abstract

In the version of this article initially published, the first name of Flora Ascione was listed as “Floriana”; the error has been corrected in the HTML and PDF versions of the article.

Published
2023

8. IMMUNOGLOBULIN CLASS DICTATES TRANSFORMATION TRAJECTORY AND BCR STATUS OF MYC/BCL2 DOUBLE‐HIT LYMPHOMA: BIOLOGY AND CLINICAL IMPLICATIONS

Author

Casola, S., primary, Sindaco, P., additional, Lonardi, S., additional, Zanardi, F., additional, Neuman, H., additional, Lorenzi, L., additional, Balzarini, P., additional, Morello, G., additional, Varano, G., additional, Bugatti, M., additional, Chairini, M., additional, Bertolazzi, G., additional, Arima, H., additional, Ranise, C., additional, Giampaolo, S., additional, Garzon, D., additional, Capaccio, P., additional, Mainoldi, F., additional, Daffini, R., additional, Zini, S., additional, Pellegrini, V., additional, Manni, S., additional, Piazza, F., additional, Tucci, A., additional, Ferreri, A. J., additional, Pruneri, G., additional, Cabras, A., additional, Di Napoli, A., additional, Pizzi, M., additional, Ponzoni, M., additional, Mehr, R., additional, Tripodo, C., additional, and Facchetti, F., additional

Published
2023
Full Text
View/download PDF

9. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease

Author

Pipitone, R.M., primary, Malvestiti, F., additional, Pennisi, G., additional, Jamialahmadi, O., additional, Dongiovanni, P., additional, Bertolazzi, G., additional, Pihlajamäki, J., additional, Yki-Järvinen, H., additional, Vespasiani-Gentilucci, U., additional, Tavaglione, F., additional, Maurotti, S., additional, Bianco, C., additional, Di Maria, G., additional, Enea, M., additional, Fracanzani, A.L., additional, Kärjä, V., additional, Lupo, G., additional, Männistö, V., additional, Meroni, M., additional, Piciotti, R., additional, Qadri, S., additional, Zito, R., additional, Craxì, A., additional, Di Marco, V., additional, Cammà, C., additional, Tripodo, C., additional, Valenti, L., additional, Romeo, S., additional, Petta, S., additional, and Grimaudo, S., additional

Published
2023
Full Text
View/download PDF

10. OC.08.1 PROGRAMMED CELL DEATH 1 GENETIC VARIANT AND LIVER DAMAGE IN NONALCOHOLIC FATTY LIVER DISEASE

Author

Pipitone, R.M., primary, Malvestiti, F., additional, Pennisi, G., additional, Jamialahmadi, O., additional, Dongiovanni, P., additional, Bertolazzi, G., additional, Pihlajamaki, J., additional, Yki-Jarvinen, H., additional, Vespasiani-Gentilucci, U., additional, Tavaglione, F., additional, Maurotti, S., additional, Bianco, C., additional, Di Maria, G., additional, Enea, M., additional, Fracanzani, A., additional, Karja, V., additional, Lupo, G., additional, Mannisto, V., additional, Meroni, M., additional, Piciotti, R., additional, Qadri, S., additional, Zito, R., additional, Craxi, A., additional, Di Marco, V., additional, Camma, C., additional, Tripodo, C., additional, Valenti, L., additional, Romeo, S., additional, Petta, S., additional, and Grimaudo, S., additional

Published
2023
Full Text
View/download PDF

11. Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

Author

Capolla S, Garrovo C, Zorzet S, Lorenzon A, Rampazzo E, Spretz R, Pozzato G, Núñez L, Tripodo C, Macor P, and Biffi S

Subjects
Medicine (General), R5-920
Abstract

Sara Capolla,1 Chiara Garrovo,2 Sonia Zorzet,1 Andrea Lorenzon,3 Enrico Rampazzo,4 Ruben Spretz,5 Gabriele Pozzato,6 Luis Núñez,7 Claudio Tripodo,8 Paolo Macor,1,9 Stefania Biffi2 1Department of Life Sciences, University of Trieste, 2Institute for Maternal and Child Health – IRCCS “Burlo Garofolo”, Trieste, 3Animal Care Unit, Cluster in Biomedicine (CBM scrl), Trieste, Italy; 4Department of Chemistry “G. Ciamician”, University of Bologna, Bologna, Italy; 5LNK Chemsolutions LLC, Lincoln, NE, USA; 6Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy; 7Bio-Target, Inc., University of Chicago, Chicago, IL, USA; 8Department of Human Pathology, University of Palermo, Palermo, Italy; 9Callerio Foundation Onlus, Institutes of Biological Researches, Trieste, Italy Abstract: The expectations of nanoparticle (NP)-based targeted drug delivery systems in cancer, when compared with convectional therapeutic methods, are greater efficacy and reduced drug side effects due to specific cellular-level interactions. However, there are conflicting literature reports on enhanced tumor accumulation of targeted NPs, which is essential for translating their applications as improved drug-delivery systems and contrast agents in cancer imaging. In this study, we characterized biodegradable NPs conjugated with an anti-CD20 antibody for in vivo imaging and drug delivery onto tumor cells. NPs’ binding specificity mediated by anti-CD20 antibody was evaluated on MEC1 cells and chronic lymphocytic leukemia patients’ cells. The whole-body distribution of untargeted NPs and anti-CD20 NPs were compared by time-domain optical imaging in a localized human/mouse model of B-cell malignancy. These studies provided evidence that NPs’ functionalization by an anti-CD20 antibody improves tumor pharmacokinetic profiles in vivo after systemic administration and increases in vivo imaging of tumor mass compared to non-targeted NPs. Together, drug delivery and imaging probe represents a promising theranostics tool for targeting B-cell malignancies. Keywords: active targeting, optical imaging, tumor accumulation

Published
2015

12. Identification of an effective chemotherapy and DNA damage response inhibitor combination for diffuse large b cell lymphoma

Author

Chan, A., primary, Anbuselvan, A., additional, Upadhyayula, S.S., additional, Jemimah, S., additional, Jaynes, P., additional, Hoppe, M.M., additional, Wardyn, J.D., additional, Goh, J., additional, Bertolazzi, G., additional, Foiani, M., additional, O’Connor, M.J., additional, Chow, E.K., additional, Tripodo, C., additional, and Jeyasekharan, A.D., additional

Published
2022
Full Text
View/download PDF

14. Publisher Correction: Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma (Nature Materials, (2019), 18, 11, (1252-1263), 10.1038/s41563-019-0425-1)

Author

Palamidessi A., Malinverno C., Frittoli E., Corallino S., Barbieri E., Sigismund S., Beznoussenko G. V., Martini E., Garre M., Ferrara I., Tripodo C., Ascione F., Cavalcanti-Adam E. A., Li Q., Di Fiore P. P., Parazzoli D., Giavazzi F., Cerbino R., Scita G., Palamidessi A., Malinverno C., Frittoli E., Corallino S., Barbieri E., Sigismund S., Beznoussenko G.V., Martini E., Garre M., Ferrara I., Tripodo C., Ascione F., Cavalcanti-Adam E.A., Li Q., Di Fiore P.P., Parazzoli D., Giavazzi F., Cerbino R., and Scita G.

Subjects
CARCINOMA, Settore MED/08 - Anatomia Patologica
Abstract

In the version of this article initially published, equation (1) in the Methods section, now reading (Formula presented.), was missing a delta symbol following “R”. The symbol has now been restored in the HTML and PDF versions of the article.

Published
2022

15. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ

Author

Della Chiara, G, Gervasoni, F, Fakiola, M, Godano, C, D'Oria, C, Azzolin, L, Bonnal, R, Moreni, G, Drufuca, L, Rossetti, G, Ranzani, V, Bason, R, De Simone, M, Panariello, F, Ferrari, I, Fabbris, T, Zanconato, F, Forcato, M, Romano, O, Caroli, J, Gruarin, P, Sarnicola, M, Cordenonsi, M, Bardelli, A, Zucchini, N, Ceretti, A, Mariani, N, Cassingena, A, Sartore-Bianchi, A, Testa, G, Gianotti, L, Opocher, E, Pisati, F, Tripodo, C, Macino, G, Siena, S, Bicciato, S, Piccolo, S, Pagani, M, Della Chiara G., Gervasoni F., Fakiola M., Godano C., D'Oria C., Azzolin L., Bonnal R. J. P., Moreni G., Drufuca L., Rossetti G., Ranzani V., Bason R., De Simone M., Panariello F., Ferrari I., Fabbris T., Zanconato F., Forcato M., Romano O., Caroli J., Gruarin P., Sarnicola M. L., Cordenonsi M., Bardelli A., Zucchini N., Ceretti A. P., Mariani N. M., Cassingena A., Sartore-Bianchi A., Testa G., Gianotti L., Opocher E., Pisati F., Tripodo C., Macino G., Siena S., Bicciato S., Piccolo S., Pagani M., Della Chiara, G, Gervasoni, F, Fakiola, M, Godano, C, D'Oria, C, Azzolin, L, Bonnal, R, Moreni, G, Drufuca, L, Rossetti, G, Ranzani, V, Bason, R, De Simone, M, Panariello, F, Ferrari, I, Fabbris, T, Zanconato, F, Forcato, M, Romano, O, Caroli, J, Gruarin, P, Sarnicola, M, Cordenonsi, M, Bardelli, A, Zucchini, N, Ceretti, A, Mariani, N, Cassingena, A, Sartore-Bianchi, A, Testa, G, Gianotti, L, Opocher, E, Pisati, F, Tripodo, C, Macino, G, Siena, S, Bicciato, S, Piccolo, S, Pagani, M, Della Chiara G., Gervasoni F., Fakiola M., Godano C., D'Oria C., Azzolin L., Bonnal R. J. P., Moreni G., Drufuca L., Rossetti G., Ranzani V., Bason R., De Simone M., Panariello F., Ferrari I., Fabbris T., Zanconato F., Forcato M., Romano O., Caroli J., Gruarin P., Sarnicola M. L., Cordenonsi M., Bardelli A., Zucchini N., Ceretti A. P., Mariani N. M., Cassingena A., Sartore-Bianchi A., Testa G., Gianotti L., Opocher E., Pisati F., Tripodo C., Macino G., Siena S., Bicciato S., Piccolo S., and Pagani M.

Abstract

Cancer is characterized by pervasive epigenetic alterations with enhancer dysfunction orchestrating the aberrant cancer transcriptional programs and transcriptional dependencies. Here, we epigenetically characterize human colorectal cancer (CRC) using de novo chromatin state discovery on a library of different patient-derived organoids. By exploring this resource, we unveil a tumor-specific deregulated enhancerome that is cancer cell-intrinsic and independent of interpatient heterogeneity. We show that the transcriptional coactivators YAP/TAZ act as key regulators of the conserved CRC gained enhancers. The same YAP/TAZ-bound enhancers display active chromatin profiles across diverse human tumors, highlighting a pan-cancer epigenetic rewiring which at single-cell level distinguishes malignant from normal cell populations. YAP/TAZ inhibition in established tumor organoids causes extensive cell death unveiling their essential role in tumor maintenance. This work indicates a common layer of YAP/TAZ-fueled enhancer reprogramming that is key for the cancer cell state and can be exploited for the development of improved therapeutic avenues.

Published
2021

16. Procto-Glyvenol© accelerates the natural healing process of wounds: a pre-clinical study.

Author

MALINVERNO, M., CALLEGARI, E., PIRONA, L., PELLERANI, I., BELMONTE, B., TRIPODO, C., ANGELICO, P., and BIONDI, S.

Abstract

OBJECTIVE: Hemorrhoids are a common anorectal disease that causes pain, itching, and burning. The prevalence of hemorrhoids is estimated to be as high as 36% in the general population, with approximately 50% of individuals experiencing symptomatic hemorrhoids at least once in their life. Middle age, obesity, and pregnancy are risk factors. The combination of tribenoside and lidocaine (Procto-Glyvenol©, Recordati) has been used for decades to treat low-grade hemorrhoids, and its efficacy and safety are well supported by clinical experience. Tribenoside has been shown to have an anti-inflammatory effect, ameliorate the local microcirculation and vascular tone, and promote the healing of basement membrane. However, the molecular mechanism behind its wound-healing properties is still unclear. MATERIALS AND METHODS: Human dermal fibroblasts were used to test the effect of tribenoside on cell proliferation, cell migration, and production of reactive oxygen species in vitro. Full-thickness excisional wound model in rats was used to test the wound-healing properties of Procto-Glyvenol© in vivo. RESULTS: Tribenoside has been found to increase the migration rate of fibroblasts in vitro and to improve the wound healing process by promoting re-epithelialization in rats. Furthermore, novel antioxidant activity of tribenoside has been reported, which may represent a further mechanism of action in wound healing. CONCLUSIONS: Procto-Glyvenol© improves the natural healing process of wounds by stimulating cell migration and protecting against the toxic effects of reactive oxygen species. Therefore, it may represent a first-line treatment for hemorrhoids, which are a significant medical and socioeconomic problem that can deteriorate the quality of life. [ABSTRACT FROM AUTHOR]

Published
2023

18. Hematopoietic stem cell function in b-thalassemia is impaired and is rescued by targeting the bone marrow niche

Author

Aprile, A, Gulino, A, Storto, M, Villa, I, Beretta, S, Merelli, I, Rubinacci, A, Ponzoni, M, Marktel, S, Tripodo, C, Lidonnici, M, Ferrari, G, Aprile A., Gulino A., Storto M., Villa I., Beretta S., Merelli I., Rubinacci A., Ponzoni M., Marktel S., Tripodo C., Lidonnici M. R., Ferrari G., Aprile, A, Gulino, A, Storto, M, Villa, I, Beretta, S, Merelli, I, Rubinacci, A, Ponzoni, M, Marktel, S, Tripodo, C, Lidonnici, M, Ferrari, G, Aprile A., Gulino A., Storto M., Villa I., Beretta S., Merelli I., Rubinacci A., Ponzoni M., Marktel S., Tripodo C., Lidonnici M. R., and Ferrari G.

Abstract

Hematopoietic stem cells (HSCs) are regulated by signals from the bone marrow (BM) niche that tune hematopoiesis at steady state and in hematologic disorders. To understand HSC-niche interactions in altered nonmalignant homeostasis, we selected b-thalassemia, a hemoglobin disorder, as a paradigm. In this severe congenital anemia, alterations secondary to the primary hemoglobin defect have a potential impact on HSC-niche cross talk. We report that HSCs in thalassemic mice (th3) have an impaired function, caused by the interaction with an altered BM niche. The HSC self-renewal defect is rescued after cell transplantation into a normal microenvironment, thus proving the active role of the BM stroma. Consistent with the common finding of osteoporosis in patients, we found reduced bone deposition with decreased levels of parathyroid hormone (PTH), which is a key regulator of bone metabolism but also of HSC activity. In vivo activation of PTH signaling through the reestablished Jagged1 and osteopontin levels correlated with the rescue of the functional pool of th3 HSCs by correcting HSC-niche cross talk. Reduced HSC quiescence was confirmed in thalassemic patients, along with altered features of the BM stromal niche. Our findings reveal a defect in HSCs in b-thalassemia induced by an altered BM microenvironment and provide novel and relevant insight for improving transplantation and gene therapy approaches.

Published
2020

19. Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas

Author

L'Imperio, V, Morello, G, Vegliante, M, Cancila, V, Bertolazzi, G, Mazzara, S, Belmonte, B, Mangogna, A, Balzarini, P, Corral, L, Lopez, G, Di Napoli, A, Facchetti, F, Pagni, F, Tripodo, C, L'Imperio, Vincenzo, Morello, Gaia, Vegliante, Maria Carmela, Cancila, Valeria, Bertolazzi, Giorgio, Mazzara, Saveria, Belmonte, Beatrice, Mangogna, Alessandro, Balzarini, Piera, Corral, Lilia, Lopez, Gianluca, Di Napoli, Arianna, Facchetti, Fabio, Pagni, Fabio, Tripodo, Claudio, L'Imperio, V, Morello, G, Vegliante, M, Cancila, V, Bertolazzi, G, Mazzara, S, Belmonte, B, Mangogna, A, Balzarini, P, Corral, L, Lopez, G, Di Napoli, A, Facchetti, F, Pagni, F, Tripodo, C, L'Imperio, Vincenzo, Morello, Gaia, Vegliante, Maria Carmela, Cancila, Valeria, Bertolazzi, Giorgio, Mazzara, Saveria, Belmonte, Beatrice, Mangogna, Alessandro, Balzarini, Piera, Corral, Lilia, Lopez, Gianluca, Di Napoli, Arianna, Facchetti, Fabio, Pagni, Fabio, and Tripodo, Claudio

Abstract

The GC reaction results in the selection of B cells acquiring effector Ig secreting ability by progressing toward plasmablastic differentiation. This transition is associated with exclusion from the GC microenvironment. The aberrant expansion of plasmablastic elements within the GC fringes configures an atypical condition, the biological characteristics of which have not been defined yet. We investigated the in situ immunophenotypical and transcriptional characteristics of a nonclonal germinotropic expansion of plasmablastic elements (GEx) occurring in the tonsil of a young patient. Compared to neighboring GC and perifollicular regions, the GEx showed a distinctive signature featuring key regulators of plasmacytic differentiation, cytokine signaling, and cell metabolism. The GEx signature was tested in the setting of diffuse large B-cell lymphoma (DLBCL) as a prototypical model of lymphomagenesis encompassing transformation at different stages of GC and post-GC functional differentiation. The signature outlined DLBCL clusters with different immune microenvironment composition and enrichment in genetic subtypes. This report represents the first insight into the transcriptional features of a germinotropic plasmablastic burst, shedding light into the molecular hallmarks of B cells undergoing plasmablastic differentiation and aberrant expansion within the noncanonical setting of the GC microenvironment.

Published
2022

23. P1397: CHRONICALLY REDUCED LEVELS OF THROMBOPOIETIN IMPAIR HEMATOPOIETIC STEM CELL FUNCTION AND MEGAKARYOCYTE BONE MARROW NICHE

Author

Aprile, A., primary, Storto, M., additional, Malara, A., additional, Gulino, A., additional, Raggi, L., additional, Sighinolfi, S., additional, Beretta, S., additional, Merelli, I., additional, Marktel, S., additional, Ponzoni, M., additional, Tripodo, C., additional, Balduini, A., additional, and Ferrari, G., additional

Published
2022
Full Text
View/download PDF

24. P1519: EXPLORING THE ROLE OF FGF23 IN BETA-THALASSEMIA: A NOVEL THERAPEUTIC TARGET TO AMELIORATE ALTERED INTERACTIONS BETWEEN HSC AND BONE MARROW NICHE

Author

Raggi, L., primary, Aprile, A., additional, Bolamperti, S., additional, Villa, I., additional, Storto, M., additional, Morello, G., additional, Marktel, S., additional, Tripodo, C., additional, Cappellini, M. D., additional, Motta, I., additional, Rubinacci, A., additional, and Ferrari, G., additional

Published
2022
Full Text
View/download PDF

26. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition

Author

Sapienza, M R, Fuligni, F, Agostinelli, C, Tripodo, C, Righi, S, Laginestra, M A, Pileri, Jr, A, Mancini, M, Rossi, M, Ricci, F, Gazzola, A, Melle, F, Mannu, C, Ulbar, F, Arpinati, M, Paulli, M, Maeda, T, Gibellini, D, Pagano, L, Pimpinelli, N, Santucci, M, Cerroni, L, Croce, C M, Facchetti, F, Piccaluga, P P, and Pileri, S A

Published
2014
Full Text
View/download PDF

31. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis

Author

Florena, A.M., Tripodo, C., Di Bernardo, A., Iannitto, E., Guarnotta, C., Porcasi, R., Ingrao, S., Abbadessa, V., and Franco, V.

Subjects
Thrombocythemia -- Physiological aspects, Thrombocythemia -- Research, Thrombocytosis -- Physiological aspects, Thrombocytosis -- Research, Apoptosis -- Research, Apoptosis -- Physiological aspects, Myelofibrosis -- Physiological aspects, Myelofibrosis -- Research, Bone marrow cells -- Physiological aspects, Bone marrow cells -- Research, Health
Published
2009

32. Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue (Annals of Oncology (2018) 29 (2363-2370) DOI: 10.1093/annonc/mdy450)

Author

Ciavarella S., Vegliante M. C., Fabbri M., De Summa S., Melle F., Motta G., De Iuliis V., Opinto G., Enjuanes A., Rega S., Gulino A., Agostinelli C., Scattone A., Tommasi S., Mangia A., Mele F., Simone G., Zito A. F., Ingravallo G., Vitolo U., Chiappella A., Tarella C., Gianni A. M., Rambaldi A., Zinzani P. L., Casadei B., Derenzini E., Loseto G., Pileri A., Tabanelli V., Fiori S., Rivas-Delgado A., Lopez-Guillermo A., Venesio T., Sapino A., Campo E., Tripodo C., Guarini A., Pileri S. A., Ciavarella S., Vegliante M.C., Fabbri M., De Summa S., Melle F., Motta G., De Iuliis V., Opinto G., Enjuanes A., Rega S., Gulino A., Agostinelli C., Scattone A., Tommasi S., Mangia A., Mele F., Simone G., Zito A.F., Ingravallo G., Vitolo U., Chiappella A., Tarella C., Gianni A.M., Rambaldi A., Zinzani P.L., Casadei B., Derenzini E., Loseto G., Pileri A., Tabanelli V., Fiori S., Rivas-Delgado A., Lopez-Guillermo A., Venesio T., Sapino A., Campo E., Tripodo C., Guarini A., and Pileri S.A.

Subjects
DLBCL microenvironment, gene expression DLBCL
Abstract

The affiliations of authors T. Venesio and A. Sapino were originally incorrect. These have now been corrected as per the author listing above.

Published
2019

33. Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) (Virchows Archiv, (2019), 475, 4, (513-518), 10.1007/s00428-019-02637-2)

Author

Di Napoli A., Remotti D., Agostinelli C., Ambrosio M. R., Ascani S., Carbone A., Facchetti F., Lazzi S., Leoncini L., Lucioni M., Novero D., Pileri S., Ponzoni M., Sabattini E., Tripodo C., Zamo A., Paulli M., Ruco L., Di Napoli A., Remotti D., Agostinelli C., Ambrosio M.R., Ascani S., Carbone A., Facchetti F., Lazzi S., Leoncini L., Lucioni M., Novero D., Pileri S., Ponzoni M., Sabattini E., Tripodo C., Zamo A., Paulli M., and Ruco L.

Subjects
mature aggressive B cell lymphoma, diagnosis in the double/triple hit lymphoma, Settore MED/08 - Anatomia Patologica
Abstract

The Acknowledgments section of this article has been corrected to 1) correct the formatting of Arianna Di Napoli's name to 'DiNapoli A', and 2) to include the name of Alessandro Corsi which was omitted in the original Lazio Group of Haematopathologist list. No further changes have been made to the publication. The corrected Acknowledgments section is as follows:.

Published
2019

34. DIGITAL SPATIAL PROFILING OF DIFFUSE LARGE B‐CELL LYMPHOMAS REVEALS STING AS AN IMMUNE‐RELATED DETERMINANT OF SURVIVAL AFTER R‐CHOP THERAPY

Author

Hoppe, M. M, primary, Fan, S, additional, Jaynes, P, additional, Peng, Y, additional, Liu, X, additional, De Mel, S, additional, Poon, L, additional, Chan, E, additional, Lee, J, additional, Chee, Y. L, additional, Ong, C. K, additional, Tang, T, additional, Lim, S. T, additional, Chng, W. J, additional, Grigoropoulos, N. F, additional, VanSchoiack, A, additional, Bertolazzi, G, additional, Ng, Siok‐B, additional, Tripodo, C, additional, and Jeyasekharan, A. D, additional

Published
2021
Full Text
View/download PDF

35. MYC, BCL2 AND BCL6 COEXPRESSION PATTERNS AT SINGLE‐CELL RESOLUTION RE‐DEFINE DOUBLE EXPRESSOR LYMPHOMAS

Author

Hoppe, M. M, primary, Jaynes, P, additional, Fan, S, additional, Peng, Y, additional, Hoang, P. M, additional, Liu, X, additional, De Mel, S, additional, Poon, L, additional, Chan, E, additional, Lee, J, additional, Chee, Y. L, additional, Ong, C. K, additional, Tang, T, additional, Lim, S. T, additional, Grigoropoulos, N. F, additional, Tan, S.‐Y, additional, Hue, S. S.‐S, additional, Chang, S.‐T, additional, Chuang, S.‐S, additional, Li, S, additional, Khoury, J. D, additional, Choi, H, additional, Farinha, P, additional, Mottok, A, additional, Scott, D. W, additional, Chng, Wee‐J, additional, Ng, S.‐B, additional, Tripodo, C, additional, and Jeyasekharan, A. D, additional

Published
2021
Full Text
View/download PDF

43. Histological features and ki-67 index in cervical atypical lesions

Author

Cabibi, D., Giovannelli, L., Cacciatore, M., Tripodo, C., Ammatuna, P., Aragona F., and Alletti, T. Gueli

Subjects
Cervical cancer -- Risk factors, Cervical cancer -- Genetic aspects, Cervical cancer -- Diagnosis, Cervical cancer -- Care and treatment, Papillomavirus infections -- Complications and side effects, Papillomavirus infections -- Genetic aspects, Papillomavirus infections -- Research, Polymerase chain reaction -- Usage, Biological sciences
Abstract

Abstract: One of the most frequent challenges in routine diagnostic assessment of cervical biopsies consists of some lesions in which histological features of HPV infection are either inconsistently present or [...]

Published
2008

48. The Natriuretic system in Human Salivary gland health and disease: potential use to diagnose early stages of malignancy in salivary glands

Author

Leone, A., Gulino, A., Belmonte, B., George, A., Geagea, Arancio, W., Tripodo, C., Miletich, I., Leone, A, Gulino, A, Belmonte, B, George, A, Geagea, Arancio, W, Tripodo, C, and Miletich, I.

Subjects
Salivary gland, Settore BIO/17 - Istologia, Natriuretic System, ANP, NPR, Settore BIO/11 - Biologia Molecolare, Settore MED/08 - Anatomia Patologica
Published
2017

49. Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue

Author

Ciavarella, S., primary, Vegliante, M.C., additional, Fabbri, M., additional, De Summa, S., additional, Melle, F., additional, Motta, G., additional, De Iuliis, V., additional, Opinto, G., additional, Enjuanes, A., additional, Rega, S., additional, Gulino, A., additional, Agostinelli, C., additional, Scattone, A., additional, Tommasi, S., additional, Mangia, A., additional, Mele, F., additional, Simone, G., additional, Zito, A.F., additional, Ingravallo, G., additional, Vitolo, U., additional, Chiappella, A., additional, Tarella, C., additional, Gianni, A.M., additional, Rambaldi, A., additional, Zinzani, P.L., additional, Casadei, B., additional, Derenzini, E., additional, Loseto, G., additional, Pileri, A., additional, Tabanelli, V., additional, Fiori, S., additional, Rivas-Delgado, A., additional, López-Guillermo, A., additional, Venesio, T., additional, Sapino, A., additional, Campo, E., additional, Tripodo, C., additional, Guarini, A., additional, and Pileri, S.A., additional

Published
2019
Full Text
View/download PDF

50. OA14.06 Hyperprogressive Disease in Advanced Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Author

Lo Russo, G., primary, Signorelli, D., additional, Proto, C., additional, Galli, G., additional, Prelaj, A., additional, Ferrara, R., additional, Sommariva, M., additional, Moro, M., additional, Cancila, V., additional, Ganzinelli, M., additional, Brich, S., additional, Sangaletti, S., additional, Pruneri, G., additional, Tripodo, C., additional, Colombo, M.P., additional, Rivoltini, L., additional, Balsari, A., additional, Sozzi, G., additional, Boeri, M., additional, and Garassino, M., additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results